ClinicalTrials.Veeva

Menu

A Deep Learning Model for Blood Volume Estimation From Multi-modal Ultrasound

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Enrolling

Conditions

Machine Learning
Blood Volume Analysis
Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT06957587
2025-KY-228(K)

Details and patient eligibility

About

  1. Background & Rationale:

    Accurate assessment of a patient's blood volume (BV) status before surgery is critical for preventing perioperative complications. However, there is currently no clinically feasible, accurate, and non-invasive method for direct BV quantification. We hypothesize that dynamic ultrasound videos of major blood vessels contain rich, sub-visual spatiotemporal information about vascular compliance and filling that can be leveraged to estimate BV.

  2. Objective:

    To develop and validate a deep learning model that integrates multi-modal ultrasound video data to achieve non-invasive, quantitative estimation of preoperative blood volume.

  3. Study Design:

    A prospective, single-center, observational study.

  4. Methods:

    Participants: Adult patients scheduled for surgery.

    Data Acquisition:

    Input (Features): Preoperative ultrasound video clips will be recorded in standardized views of four key vessels: the Internal Jugular Vein (IJV), Subclavian Vein (SCV), Inferior Vena Cava (IVC), and Common Carotid Artery (CA).

    Target (Label): The true Blood Volume (BV) will be calculated for each patient using the acute normovolemic hemodilution (ANH) method. The change in hemoglobin concentration before and after this process is used to calculate the total blood volume with high clinical reliability.

    Model Development: A hybrid deep learning architecture (e.g., CNN + LSTM/Transformer) will be trained to extract features from the ultrasound videos and learn the complex, non-linear mapping to the BV value derived from ANH. The model will be trained and internally validated using a k-fold cross-validation approach.

  5. Expected Outcome & Significance:

We anticipate the development of a novel, end-to-end deep learning model capable of providing a quantitative BV estimate from routine ultrasound scans. This technology has the potential to revolutionize perioperative fluid management by offering a rapid, non-invasive, and accurate tool for objective volume status assessment, ultimately guiding personalized therapy and improving patient outcomes.

Enrollment

800 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Agree to join this study and sign the informed consent form;
  • Age between 18 and 75 years old (inclusive);
  • BMI (body mass index) is between 18 and 30 kg/m2;
  • American Society of Anesthesiologists (ASA) grades I-II

Exclusion criteria

  • Preoperative hemoglobin (Hb) <10g/dl
  • Cardiac dysfunction (NYHA class III-IV), respiratory dysfunction (ATS class 2-4), history of liver and kidney dysfunction (such as transaminase / albumin / bilirubin abnormalities, hepatitis history, serum creatinine / urea nitrogen rise, etc.), nervous system abnormalities (those who cannot cooperate due to stroke or its sequelae, Alzheimer, etc.);
  • The ultrasonic display of inferior vena cava, internal jugular vein, subclavian vein or common carotid artery is extremely poor, venous thrombosis or anatomical abnormalities;
  • Multiple injury with chest, abdomen or brain;
  • Pregnant woman

Trial design

800 participants in 1 patient group

patients prepare to receive surgery
Description:
The patients aged 18-75 years old prepare to receive surgery will be assigned into the cohort.

Trial contacts and locations

1

Loading...

Central trial contact

xiuxiu sun, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems